BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4144372)

  • 21. Mechanism of anti-inflammatory activity of -adrenoceptor blocking agents.
    Bhalla TN; Sinha JN; Tangri KK; Bhargava KP
    Eur J Pharmacol; 1972 Dec; 20(3):366-8. PubMed ID: 4404943
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
    Kadatz R; Diederen W
    Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of some -adrenergic blocking agents on the acetylcholine content of heart. An experimental study in mice.
    Khanna NK
    Eur J Pharmacol; 1972 Feb; 17(2):309-11. PubMed ID: 4402099
    [No Abstract]   [Full Text] [Related]  

  • 24. Coronary vasomotor responses to cardiac sympathetic nerve stimulation in the dog treated with beta adrenoceptor blocking agents.
    Takenaka F; Ishihara T
    Jpn J Pharmacol; 1972 Oct; 22(5):721-3. PubMed ID: 4405463
    [No Abstract]   [Full Text] [Related]  

  • 25. Salivation in mice as an index of adrenergic activity. 3. Partial temperature-dependence of adrenergic drug effects.
    Maling HM; Koppanyi T
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):344-57. PubMed ID: 4403620
    [No Abstract]   [Full Text] [Related]  

  • 26. Action of beta-adrenolytics on the isolated guinea-pig atria.
    Grodzińska L; Gryglewski R
    Arch Int Pharmacodyn Ther; 1971 May; 191(1):133-41. PubMed ID: 4397624
    [No Abstract]   [Full Text] [Related]  

  • 27. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
    [No Abstract]   [Full Text] [Related]  

  • 28. [Specific differences between the adrenergic beta receptors of the heart and coronary vessels].
    Bayer BL; Mentz P; Förster W
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):341-7. PubMed ID: 4405155
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Eur J Clin Pharmacol; 1971 Sep; 3(4):204-8. PubMed ID: 4402827
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.
    Tachikawa S; Takenaka T
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371
    [No Abstract]   [Full Text] [Related]  

  • 31. [Extrapancreatic effects of sulfonylurea compounds. V. Studies on the antilipolytic effect of glibornuride].
    Rosak C; Bartelt KM; Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2181. PubMed ID: 4146791
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of stellate ganglion stimulation on myocardial blood flow, oxygen consumption, and cardiac efficiency during beta-adrenoceptor blockade.
    Nayler WG; Carson V
    Cardiovasc Res; 1973 Jan; 7(1):22-9. PubMed ID: 4144407
    [No Abstract]   [Full Text] [Related]  

  • 33. Raised serum-lipids unaffected by beta-blockade.
    Lloyd-Mostyn RH; Krikler DM
    Lancet; 1970 Nov; 2(7681):1040. PubMed ID: 4098084
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative studies on the effect of 2 beta receptor blockaders on elevated blood pressure and kidney function].
    Anlauf M; Heimsoth V; Ulrych M; Bock KD
    Verh Dtsch Ges Inn Med; 1969; 75():169-72. PubMed ID: 4395389
    [No Abstract]   [Full Text] [Related]  

  • 35. The development of new antidysrhythmic drugs.
    Williams EM
    Schweiz Med Wochenschr; 1973 Feb; 103(8):262-71. PubMed ID: 4144416
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical evaluation of beta-receptor blockers in anesthesia. 4. Anti-arrhythmic effects of Y-6124].
    Fujita T; Miyazaki M
    Masui; 1972 May; 21(5):450-7. PubMed ID: 4403862
    [No Abstract]   [Full Text] [Related]  

  • 37. The selectivity of -adrenergic compounds. II. Studies on the mimetic compound Salbutamol and the lytic compound practolol.
    Grana E; Mastelli OC; Zonta F; Lucchelli A; Santagostino MG
    Farmaco Sci; 1972 Oct; 27(10):842-54. PubMed ID: 4404432
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of 1-(isopropylamino)-3-(m-toyloxy)-2-propanol hydrochloride (Doberol) on the bronchial system after oral administration].
    Günthner W
    Eur J Clin Pharmacol; 1972 Jun; 4(3):185-90. PubMed ID: 4144065
    [No Abstract]   [Full Text] [Related]  

  • 39. [Influence of an alpha- and beta-receptor blockade on the dynamics of insulin secretion in dogs following increased dosage of various sulfonylureas].
    Cordes U; Beyer J; Sell G; Haupt E; Schöffling K
    Verh Dtsch Ges Inn Med; 1971; 77():1069-72. PubMed ID: 4405360
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of the adrenergic drugs on the electrical responses of the rabbit isolated heart atrium.
    Smejkal V; Mironneau J; Ojeda C; Gargouil YM
    Physiol Bohemoslov; 1970; 19(1):19-22. PubMed ID: 4394505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.